| Toceranib |
| 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide |
| (CAS 356068-94-5) |
 |
| Description： |
Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
|
| Product No. |
KT00862 |
| Product Name |
Toceranib |
| Synonyms |
PHA 291639; SU 11654 |
| Formal Name |
5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide |
| CAS Number |
356068-94-5 |
| Molecular Formula |
C22H25FN4O2 |
| Formula Weight |
396.46 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AC710
AC710 Mesylate
Amuvatinib
Apatinib
Axitinib
AZD2932
BIBF 1120
BMS-690514
|
|
